Measure against baseline weekly
Anchor-compound logic: why the blend is set by GHK-Cu KLOWs fixed 0.10 mL dose is calibrated around GHK-Cu as the anchor compound
In this context, postbiotics are more plausibly positioned not as primary weight-loss interventions, but as nutritional strategies that may be continued after GLP-1based pharmacotherapy to support metabolic stability, mitigate weight regain, and preserve lean mass during the post-treatment phase ( From a clinical nutrition perspective, postbiotics should not be positioned as weight-loss agents, nor as substitutes for pharmacological GLP-1 receptor agonists
Exenatide, released in 2005 as Byetta, is the oldest GLP analog
Similarly, IM injections offer an effective alternative, though they are slightly slower than IV therapy in absorption